HMT LLP advised Agathos on their investment in fast-growing healthcare recruitment business Hunter Healthcare to back the management-buyout.
Hunter is a London-headquartered, specialist healthcare recruitment business that places interim and permanent candidates into roles in the NHS, private healthcare and life science sectors. Hunter is known for its niche sector focus, high calibre candidates, depth of market knowledge, and the strength of its relationships with clients.
Hunter has developed an exceptional position in healthcare recruitment for non-clinical roles, with revenues growing to £44m in the current financial year. The business has a vision to be the global recruitment partner of choice to healthcare organisations. It is well positioned to serve its rapidly evolving healthcare and life science markets, including supporting the NHS with its reorganisation of Integrated Care Systems, the elective care backlog and the continued shift towards digitalisation.
Agathos’s investment will facilitate the management buy-out of Hunter Healthcare and support the senior leadership team in delivering ambitious growth plans. Internationally, Hunter has started serving the diagnostic and medical devices sector in the USA and plans on building its footprint in these fast-growing market segments over the months ahead.
HMT undertook financial due diligence for Agathos on this transaction.
John Butterworth, Investment Manager at Agathos commented:
“It was a pleasure working with HMT during this due diligence engagement. Paul and his team were flexible from the outset, worked at pace and delivered a very high standard of client service””
Paul Read commented:
“We are delighted to have advised Agathos and Hunter Healthcare on the management buy-out. The business has grown rapidly since inception and are on the right track to realise their national and international growth plans. We look forward to working with them in the future.”